| 1 |
国家卫生健康委员会．2022年国家医疗服务与质量安全报告[M]. 北京：科学技术文献出版社，2023.
|
| 2 |
Anderson DJ, Locke JE. Progress towards solving the donor organ shortage[J]. Nat Rev Nephrol, 2023, 19(2)：83-84.
|
| 3 |
Sykes M, Sachs DH. Progress in xenotransplantation: overcoming immune barriers[J]. Nat Rev Nephrol, 2022, 18(12)：745-761.
|
| 4 |
Matas AJ, Montgomery RA, Schold JD. The organ shortage continues to be a crisis for patients with end-stage kidney disease[J]. JAMA Surg, 2023, 158(8)：787-788.
|
| 5 |
国家卫生和计划生育委员会，公安部，交通运输部，等．关于建立人体捐献器官转运绿色通道的通知[EB/OL]. (2016-05-06) [2025-06-10].
URL
|
| 6 |
中华人民共和国国务院．人体器官捐献和移植条例[EB/OL].(2023-12-14)[2025-06-10].
URL
|
| 7 |
Zhang Q, Tong J, Zhou W, et al. Antibacterial and antioxidant chitosan nanoparticles improve the preservation effect for donor kidneys in vitro[J]. Carbohydr Polym, 2022, 287：119326.
|
| 8 |
Zhou W, Zhong Z, Lin D. Hypothermic oxygenated perfusion inhibits HECTD3-mediated TRAF3 polyubiquitination to alleviate DCD liver ischemia-reperfusion injury[J]. Cell Death Dis, 2021, 12(2)：211.
|
| 9 |
Liang H, Zhang P, Yu B, et al. Machine perfusion combined with antibiotics prevents donor-derived infections caused by multidrug-resistant bacteria[J]. Am J Transplant, 2022, 22(7)：1791-1803.
|
| 10 |
Luo J, Hu Y, Qiao Y, et al. Hypothermic oxygenated machine perfusion promotes mitophagy flux against hypoxia-ischemic injury in rat DCD liver[J]. Int J Mol Sci, 2023, 24(6)：5403.
|
| 11 |
Qiao Y, Li J, Bian S, et al. Application of biocompatible custom ceria nanoparticles in improving the quality of liver grafts for transplantation[J]. Nano Research, 2023, 16(4)：5176-5188.
|
| 12 |
国家卫生健康委、国家中医药局、国家疾控局. "十四五"全民健康信息化规划[EB/OL].(2022-11-09)[2025-06-10].
URL
|
| 13 |
宋伟，刘谋友，杨余富，等. 北斗卫星导航系统在卫勤保障中的应用探讨[J]. 医疗装备，2012, 25(2): 17-19.
|
| 14 |
张秋军，孙婕，王泽阳，等. 基于移动物联网的健康管理平台在医疗设备智能化管理中的应用[J]. 中国医疗设备，2025, 40(8): 58-63.
|
| 15 |
Centers for Medicare and Medicaid Services. State operations manual appendix Y[a1][2]-organ procurement organization (OPO) interpretive guidance[EB/OL]. (2018-01-05) [2025-06-10].
URL
|
| 16 |
Transplantation Society of Australia and New Zealand. National Standard Operation Procedures - Packaging, Labelling, Storage & Documentation of deceased donor vessels [EB/OL]. (2020-04-01) [2025-06-10].
URL
|
| 17 |
De Beule J, Fieuws S, Monbaliu D, et al. The effect of IGL-1 preservation solution on outcome after kidney transplantation: a retrospective single-center analysis[J]. Am J Transplant, 2021, 21(2)：830-837.
|
| 18 |
Panayotova GG, Lunsford KE, Quillin RC, et al. Portable hypothermic oxygenated machine perfusion for organ preservation in liver transplantation: a randomized, open-label, clinical trial[J]. Hepatology, 2024, 79(5)：1033-1047.
|
| 19 |
van Rijn R, Schurink IJ, de Vries Y, et al. Hypothermic machine perfusion in liver transplantation-a randomized trial[J]. N Engl J Med, 2021, 384(15)：1391-1401.
|
| 20 |
Malinoski D, Saunders C, Swain S, et al. Hypothermia or machine perfusion in kidney donors[J]. N Engl J Med, 2023, 388(5)：418-426.
|
| 21 |
Schlegel A, Mergental H, Fondevila C, et al. Machine perfusion of the liver and bioengineering[J]. J Hepatol, 2023, 78(6)：1181-1198.
|
| 22 |
Schlegel A, Porte R, Dutkowski P. Protective mechanisms and current clinical evidence of hypothermic oxygenated machine perfusion (HOPE) in preventing post-transplant cholangiopathy[J]. J Hepatol, 2022, 76(6)：1330-1347.
|
| 23 |
Kang XY, Cheng JY, Ge WY, et al. Revolution in organ preservation: technological exploration[J]. Acta Biomater, 2025, 199：50-73.
|
| 24 |
中国肝移植注册中心，国家肝脏移植质控中心，国家人体捐献器官获取质控中心，等. 中国移植器官保护专家共识(2022版)[J/OL]. 中华移植杂志：电子版，2022, 16(1)：1-12.
|
| 25 |
Niroomand A, Lindstedt S. Current challenges in lung transplantation[J]. J Intern Med, 2025, 297(4)：355-365.
|
| 26 |
中华医学会器官移植学分会，中国医师协会器官移植医师分会. 遗体捐献器官获取工作指南[J/OL]. 中国医学前沿杂志：电子版，2024，16(11)：1-16.
|
| 27 |
Hosgood SA, Callaghan CJ, Wilson CH, et al. Normothermic machine perfusion versus static cold storage in donation after circulatory death kidney transplantation: a randomized controlled trial[J]. Nat Med, 2023, 29(6)：1511-1519.
|
| 28 |
Lascaris B, de Meijer VE, Porte RJ. Normothermic liver machine perfusion as a dynamic platform for regenerative purposes: What does the future have in store for us？[J]. J Hepatol, 2022, 77(3)：825-836.
|
| 29 |
Markmann JF, Abouljoud MS, Ghobrial RM. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS liver protect randomized clinical trial[J]. JAMA Surg, 2022, 157(3)：189-198.
|
| 30 |
Hann A, Lembach H, Nutu A, et al. Outcomes of normothermic machine perfusion of liver grafts in repeat liver transplantation (NAPLES initiative) [J]. Br J Surg, 2022, 109(4)：372-380.
|
| 31 |
OPTN. Organ Procurement and Transplantation Network (OPTN) Policies[EB/OL]. (2020-06-18)[2025-06-10].
URL
|
| 32 |
Roza BA, Paim SMS, Leite R, et al. Safe transport of organs and tissues for transplants: technological innovation product validation method[J]. Rev Assoc Med Bras (1992), 2023, 69(6): e20221537.
|
| 33 |
Schlegel A, Mueller M, Muller X, et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation[J]. J Hepatol, 2023，78(4)：783-793.
|
| 34 |
Husen P, Boffa C, Jochmans I, et al. Oxygenated end-hypothermic machine perfusion in expanded criteria donor kidney transplant: a randomized clinical trial[J]. JAMA Surg, 2021, 156(6)：517-525.
|
| 35 |
Mergental H, Laing RW, Kirkham AJ, et al. Transplantation of discarded livers following viability testing with normothermic machine perfusion[J]. Nat Commun, 2020, 11(1)：2939.
|
| 36 |
Meszaros AT, Hofmann J, Buch ML, et al. Mitochondrial respiration during normothermic liver machine perfusion predicts clinical outcome[J]. EBioMedicine, 202, 85：104311.
|
| 37 |
Grᶏt M, Morawski M, Zhylko A, et al. Routine end-ischemic hypothermic oxygenated machine perfusion in liver transplantation from donors after brain death: a randomized controlled trial[J]. Ann Surg, 2023, 278(5)：662-668.
|
| 38 |
Karangwa S, Panayotova G, Dutkowski P, et al. Hypothermic machine perfusion in liver transplantation[J]. Int J Surg, 2020, 82S：44-51.
|
| 39 |
Knijff LWD, van Kooten C, Ploeg RJ. The effect of hypothermic machine perfusion to ameliorate ischemia-reperfusion injury in donor organs[J]. Front Immunol, 2022, 13：848352.
|
| 30 |
Puttarajappa CM, Jorgensen D, Yabes JG, et al. Trends and impact on cold ischemia time and clinical outcomes using virtual crossmatch for deceased donor kidney transplantation in the United States[J]. Kidney Int, 2021, 100(3)：660-671.
|
| 41 |
Placona AM, Humphries C, Curran C, et al. Association of transit time with cold ischemic time in kidney transplantation[J]. JAMA Netw Open, 2021, 4(12)：e2141108.
|
| 42 |
Gorbacheva V, Fan R, Beavers A, et al. Anti-donor MHC class Ⅱalloantibody induces glomerular injury in mouse renal allografts subjected to prolonged cold ischemia[J]. J Am Soc Nephrol, 2019，30(12)：2413-2425.
|
| 43 |
中华医学会器官移植学分会，中国医师协会器官移植医师分会，中国医疗保健国际交流促进会肾脏移植学分会. 中国遗体器官捐献供肾体外低温机械灌注保存指南[J]. 器官移植，2024, 15(6)：837-845.
|
| 44 |
黄启恒，汪国营. 供肝的质量评估与保存策略[J]. 器官移植，2025, 16(4)：609-619.
|
| 45 |
胡春晓，邵景博，赵晋，等. 移植供肺的保存与功能维护[J]. 器官移植，2023, 14(2)：213-219.
|
| 46 |
郑树森. 中国器官移植发展方向——注重质量、严格规范、谋求精准、融汇大数据[J]. 手术，2016, 1(1)：1-2, 7.
|
| 47 |
石炳毅，刘志佳. 构建质量提升计划系统，促进器官移植转型发展[J]. 器官移植，2020，11(1): 1-7.
|
| 48 |
赵辉，杨扬，徐骁. 肝脏移植标准数据集[J]. 器官移植，2020，11(1)：126-175.
|
| 49 |
国家卫生健康委办公厅，国家中医药局综合司，国家疾控局综合司. 关于进一步加强医疗机构电子病历信息使用管理的通知[EB/OL].(2025-06-23)[2025-06-24].
URL
|